Biking Event
A bicycle event that simultaneously took place in Italy, Germany and the Netherlands on June 29th 2024.
Join connect
CONNECT
Cognitive decline in Nephro-Neurology: European Cooperative Target
CONNECT Action aims to coordinate research on cognitive impairment in chronic kidney disease (CKD). This requires exchanging clinical information between nephrologists and neurologists, and between neuroscientists and kidney physiologists, guided by big data analysts.
This collaborative network will define new experimental paradigms, their translational value and, in turn, focus on new interventions in the field of cognitive impairment.
Main Information
Objectives
OBJECTIVES
Working Groups
Working Groups
RESULTS
Latest News
Latest Tweets
Methodology for Neurocognitive Assessment in Patients with Kidney Diseases: Similarities & Differences
Call for applications – Methodology for Neurocognitive Assessment in Patients with Kidney Diseases: Similarities & Differences Istanbul, Turkey, 2024 COST ACTION CONNECT CA19127 Application deadlineAugust 21, 2024 Clinicians of all
Last Call for Short-Term Scientific Mission (STSM)
Last Call for Short-Term Scientific Mission (STSM) applications within the COST Action “Cognitive decline in Nephro-Neurology: European Cooperative Target (CONNECT)” Missions occurring until 15th September 2024Deadline for submission: 5th August 2024
Biking Event: raise awareness for kidney disease and kidney donation for transplantation
On June 29th 2024 – exactly at noon – the starting signal will be given for a bicycle event that simultaneously takes place in Italy, Germany and the Netherlands. The aim is
Drugs with a negative impact on cognitive functions (Part 3): Antibacterial agents in patients with chronic kidney disease
Authors: Sophie Liabeuf, Gaye Hafez, Vesna Pešić, Goce Spasovski, Mickael Bobot, Romaldas Mačiulaitis, Inga Arune Bumblyte, Ana Carina Ferreira, Ana Farinha, Jolanta Malyszko, Marion Pépin, Ziad A Massy, Robert Unwin, Giovambattista Capasso, Laila-Yasmin Mani Antibacterial agents (ABs) represent a critical component of therapy